A study has identified new potential ways to target G protein-coupled receptor (GPCR) signaling, which could lead to the development of new drugs. The research appears to involve the use of various methods, including the analysis of protein structures and the identification of biomarkers associated with certain diseases. The study's findings may have implications for the treatment of a range of conditions, including neurodegenerative diseases and other disorders.